Eman Salah El-Shafey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eman Salah El-Shafey has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Eslam Samy Elsherbiny
Biochemistry Department, Faculty of Science, Damietta University, Damietta, Egypt
4 shared publications Eslam Samy Elsherbiny
Damietta University Faculty of Science
2 shared publications- Mohamed Ahmed Abdel-Mohsen
Applied Medical Chemistry Department, Medical Research Institute, Alexandria University, Alexandria, Egypt
2 shared publications Camelia A. Abdel Malak
Chemistry Department, Faculty of Science, Damietta University, Damietta, Egypt
1 shared publication- Camelia Adly Abdel Malak
Chemistry Department, Faculty of Science, Damietta University, Damietta, Egypt
1 shared publication Morsy A. Abou Yossef
Chemistry Department, Faculty of Science, Alexandria University, Alexandria, Egypt
1 shared publication
Latest Publications
- Open Access
- 14 February 2023
- Published by Taylor & Francis in Egyptian Journal of Basic and Applied Sciences
- Vol. 10 (1) , 204-217
Therapeutic potential of a 2,2’-bipyridine-based vanadium(IV) complex on HepG2 cells: cytotoxic effects and molecular targeting
Vanadium complexes as non-platinum metallic drugs have gained considerable importance as an appropriate candidate for cancer treatment The study aimed to investigate the patent therapeutic activity of [VO (bpy)2 Cl] Cl.H2O complex in HCC cells: Viability of cells was detected by MTT method. Flow cytometry detected cell cycle, apoptosis Microtubule-associated protein 1A/1B-light chain 3 (LC3) and acid vascular organelles (AVOs) levels. ELISA was used for caspase-3 levels. AVOs was detected by fluorescence microscope. Real time PCR was assessed for Cyclin D1 gene expression HepG2 cellular growth was inhibited after treatment. Triggering of apoptosis was indicated by elevation of cells in sub G0, apoptotic phases, and the increase in caspase-3 levels. Stimulation of autophagy was reflected by the propagation of cells in G0/G1 phase, the raising of AVOs and elevation of LC3 levels. Suppression of Cyclin D1 gene expression was detected. [VO (bpy)2 Cl] Cl.H2O complex could be taken into account as a vanadium-based drug that mediated its antitumor activity on HCC cells.
- 14 February 2023
- Published by Taylor & Francis in Egyptian Journal of Basic and Applied Sciences
- Vol. 10 (1) , 204-217
Open AccessTherapeutic potential of a 2,2’-bipyridine-based vanadium(IV) complex on HepG2 cells: cytotoxic effects and molecular targeting
Vanadium complexes as non-platinum metallic drugs have gained considerable importance as an appropriate candidate for cancer treatment The study aimed to investigate the patent therapeutic activity of [VO (bpy)2 Cl] Cl.H2O complex in HCC cells: Viability of cells was detected by MTT method. Flow cytometry detected cell cycle, apoptosis Microtubule-associated protein 1A/1B-light chain 3 (LC3) and acid vascular organelles (AVOs) levels. ELISA was used for caspase-3 levels. AVOs was detected by fluorescence microscope. Real time PCR was assessed for Cyclin D1 gene expression HepG2 cellular growth was inhibited after treatment. Triggering of apoptosis was indicated by elevation of cells in sub G0, apoptotic phases, and the increase in caspase-3 levels. Stimulation of autophagy was reflected by the propagation of cells in G0/G1 phase, the raising of AVOs and elevation of LC3 levels. Suppression of Cyclin D1 gene expression was detected. [VO (bpy)2 Cl] Cl.H2O complex could be taken into account as a vanadium-based drug that mediated its antitumor activity on HCC cells.
- 1 January 2022
- Published by Egyptian Knowledge Bank in Bulletin of Egyptian Society for Physiological Sciences
- Vol. 42 (1) , 1-10
COVID-19, Wide Spread and Treatment Need
Human coronavirus, hCoV-19, is highly pathogenic with severe pneumonia linked to rapid replication of the virus and worldwide spread. Originating in Wuhan China December 2019, the current COVID-19 epidemic has grown rapidly with individual-to-person infection expanding to become a pandemic-scale global health emergency. As a pandemic, COVID-19 has led many researchers from various areas of biomedicine to pursue approaches or therapies to handle the pandemic. COVID-2019 cure is in part based on the patient's own immune system. When the over-activated immune system kills the virus, a large number of inflammatory factors are produced which lead to severe cytokine storms. This appears that the key explanation for damage to these organs may be due to a cytokine storm caused by the virus. Current therapies available-including non-specific anti-viral, antibiotics to treat secondary bacterial infections and sepsis, and inflammatory corticosteroids-fail in serious disease where the hallmark is the COVID-19-induced cytokine storm in the lung. Until now, however, no specific treatment has been found for this disease. Thus, there is a significant unmet need for safe and efficient care.
- 1 January 2022
- Published by Egyptian Knowledge Bank in Bulletin of Egyptian Society for Physiological Sciences
- Vol. 42 (1) , 1-10
COVID-19, Wide Spread and Treatment Need
Human coronavirus, hCoV-19, is highly pathogenic with severe pneumonia linked to rapid replication of the virus and worldwide spread. Originating in Wuhan China December 2019, the current COVID-19 epidemic has grown rapidly with individual-to-person infection expanding to become a pandemic-scale global health emergency. As a pandemic, COVID-19 has led many researchers from various areas of biomedicine to pursue approaches or therapies to handle the pandemic. COVID-2019 cure is in part based on the patient's own immune system. When the over-activated immune system kills the virus, a large number of inflammatory factors are produced which lead to severe cytokine storms. This appears that the key explanation for damage to these organs may be due to a cytokine storm caused by the virus. Current therapies available-including non-specific anti-viral, antibiotics to treat secondary bacterial infections and sepsis, and inflammatory corticosteroids-fail in serious disease where the hallmark is the COVID-19-induced cytokine storm in the lung. Until now, however, no specific treatment has been found for this disease. Thus, there is a significant unmet need for safe and efficient care.
- 17 August 2020
- Published by Taylor & Francis in Immunological Investigations
- Vol. 50 (8) , 1072-1084
Impact of Proinflammatory Cytokine Gene Polymorphisms and Circulating CD3 on Long-Term Renal Allograft Outcome in Egyptian Patients
The extant study aimed to explore the influence of two cytokines TNF-α − 308 and IFN-γ + 874 gene polymorphism on development of renal transplant rejection and to investigate the feasibility of Th1 cytotoxic immune reaction (CD3). It includes 152 kidney recipients were divided into two subgroups: 76 stable graft functions (SGF) and 76 allograft dysfunctions (AD) compared with 56 healthy individuals as control group. TNF-α − 308 G > A and IFN-γ + 874 A > T genetic polymorphisms were characterized using ARMS-PCR technique. CD3 protein expression was measured using ELISA Kit. The effect on transplant outcome was analyzed where, statistically significant differences of TNF-a-308 G/A were observed between AD group when compared to SGF group (OR = 0.296, 95% CI = 0.091–0.965, p = .031) in AG genotype (intermediate producer genotype). Also, AD group displayed a statistically significant increase of IFN-γ + 874 TT (high producer genotype) when compared to SGF group (OR = 0.290, 95% CI = 0.127–0.665, p = .003). The expression of CD3+ T lymphocytes in recipients with allograft dysfunction was statistically higher than that with stable allograft function and control groups (732 ± 76, 235 ± 51 and 442 ± 50) respectively and (p ≤ 0.001). In conclusion, IFN-γ + 874 T and TNF-α − 308 A alleles are risk alleles for renal transplant rejection and these two single nucleotide polymorphisms (SNPs) may be implicated in the tendency of rejection after renal transplantation. CD3 may be used as non-invasive biomarker in monitoring of rejection and avoid exposing patients for biopsy risks and sampling error.
- 17 August 2020
- Published by Taylor & Francis in Immunological Investigations
- Vol. 50 (8) , 1072-1084
Impact of Proinflammatory Cytokine Gene Polymorphisms and Circulating CD3 on Long-Term Renal Allograft Outcome in Egyptian Patients
The extant study aimed to explore the influence of two cytokines TNF-α − 308 and IFN-γ + 874 gene polymorphism on development of renal transplant rejection and to investigate the feasibility of Th1 cytotoxic immune reaction (CD3). It includes 152 kidney recipients were divided into two subgroups: 76 stable graft functions (SGF) and 76 allograft dysfunctions (AD) compared with 56 healthy individuals as control group. TNF-α − 308 G > A and IFN-γ + 874 A > T genetic polymorphisms were characterized using ARMS-PCR technique. CD3 protein expression was measured using ELISA Kit. The effect on transplant outcome was analyzed where, statistically significant differences of TNF-a-308 G/A were observed between AD group when compared to SGF group (OR = 0.296, 95% CI = 0.091–0.965, p = .031) in AG genotype (intermediate producer genotype). Also, AD group displayed a statistically significant increase of IFN-γ + 874 TT (high producer genotype) when compared to SGF group (OR = 0.290, 95% CI = 0.127–0.665, p = .003). The expression of CD3+ T lymphocytes in recipients with allograft dysfunction was statistically higher than that with stable allograft function and control groups (732 ± 76, 235 ± 51 and 442 ± 50) respectively and (p ≤ 0.001). In conclusion, IFN-γ + 874 T and TNF-α − 308 A alleles are risk alleles for renal transplant rejection and these two single nucleotide polymorphisms (SNPs) may be implicated in the tendency of rejection after renal transplantation. CD3 may be used as non-invasive biomarker in monitoring of rejection and avoid exposing patients for biopsy risks and sampling error.
- Open Access
- 26 May 2020
- Published by Bentham Science Publishers Ltd. in Current Chemical Biology
- Vol. 14 (1) , 4-13
Dual Opposed Survival-supporting and Death-promoting Roles of Autophagy in Cancer Cells: A Concise Review
Autophagy is a well-maintained process by which the cells recycle intracellular materials to maintain homeostasis in various cellular functions. However, autophagy is a defensive mechanism that maintains cell survival under antagonistic conditions, the induction of the autophagic process may substantially lead to cell death. The conflicting roles of autophagy including allowing cell survival or promoting cell death could have a troublesome impact on the efficiency of chemotherapeutic agents. Accordingly, understanding the role of autophagy in cancer is a vital need for its optimal manipulation in therapy.
- 26 May 2020
- Published by Bentham Science Publishers Ltd. in Current Chemical Biology
- Vol. 14 (1) , 4-13
Open AccessDual Opposed Survival-supporting and Death-promoting Roles of Autophagy in Cancer Cells: A Concise Review
Autophagy is a well-maintained process by which the cells recycle intracellular materials to maintain homeostasis in various cellular functions. However, autophagy is a defensive mechanism that maintains cell survival under antagonistic conditions, the induction of the autophagic process may substantially lead to cell death. The conflicting roles of autophagy including allowing cell survival or promoting cell death could have a troublesome impact on the efficiency of chemotherapeutic agents. Accordingly, understanding the role of autophagy in cancer is a vital need for its optimal manipulation in therapy.
- 21 April 2020
- Published by Springer Nature in BioMetals
- Vol. 33 (2-3) , 123-135
The role of apoptosis and autophagy in the insulin-enhancing activity of oxovanadium(IV) bipyridine complex in streptozotocin-induced diabetic mice
Metal-based therapies (e.g. Vanadium) possess an attractive proposition in medicinal treatment of diabetes mellitus. Defective insulin secretion can result from impaired β-cell function which is mediated by many process including apoptosis and autophagy. In this study. diabetes was induced by administration of streptozotocin then treatment was performed by vanadyl sulfate and [VO(bpy)2 Cl] Cl.H2O complex. Blood glucose level, AST, ALT, BUN, CR, TCHO, TG and total protein were determined in serum. MDA, NO, erythrocyte GSH and SOD were estimated. LC3 and Caspase 3 levels in pancreatic cells were assessed by flow cytometer. Histopathological investigation of pancreatic tissue was performed. Results of Diabetic group showed a significant increase in transaminases activities, TCHO, TG, MDA, NO and Caspase 3 levels and significant decrease in TP, GSH, SOD and LC3 levels. Oral administration of vanadium complex resulted in normoglycemia, significant increase in blood GSH, SOD, TP and LC3 levels, significant decrease in ALT, AST, BUN, TCHO, TG, MDA and NO and Caspase 3 levels. In addition, proliferative effect of complex prevents islet atrophy. From previous results, the insulin-enhancing effect induced by this complex indicated that this new complex can be a valuable candidate as insulin-enhancing and antioxidant compound than inorganic vanadyl sulfate.
- 21 April 2020
- Published by Springer Nature in BioMetals
- Vol. 33 (2-3) , 123-135
The role of apoptosis and autophagy in the insulin-enhancing activity of oxovanadium(IV) bipyridine complex in streptozotocin-induced diabetic mice
Metal-based therapies (e.g. Vanadium) possess an attractive proposition in medicinal treatment of diabetes mellitus. Defective insulin secretion can result from impaired β-cell function which is mediated by many process including apoptosis and autophagy. In this study. diabetes was induced by administration of streptozotocin then treatment was performed by vanadyl sulfate and [VO(bpy)2 Cl] Cl.H2O complex. Blood glucose level, AST, ALT, BUN, CR, TCHO, TG and total protein were determined in serum. MDA, NO, erythrocyte GSH and SOD were estimated. LC3 and Caspase 3 levels in pancreatic cells were assessed by flow cytometer. Histopathological investigation of pancreatic tissue was performed. Results of Diabetic group showed a significant increase in transaminases activities, TCHO, TG, MDA, NO and Caspase 3 levels and significant decrease in TP, GSH, SOD and LC3 levels. Oral administration of vanadium complex resulted in normoglycemia, significant increase in blood GSH, SOD, TP and LC3 levels, significant decrease in ALT, AST, BUN, TCHO, TG, MDA and NO and Caspase 3 levels. In addition, proliferative effect of complex prevents islet atrophy. From previous results, the insulin-enhancing effect induced by this complex indicated that this new complex can be a valuable candidate as insulin-enhancing and antioxidant compound than inorganic vanadyl sulfate.
- 24 January 2020
- Published by Bentham Science Publishers Ltd. in Anti-Cancer Agents in Medicinal Chemistry
- Vol. 19 (17) , 2130-2139
Possible Selective Cytotoxicity of Vanadium Complex on Breast Cancer Cells Involving Pathophysiological Pathways
Background: Triple-Negative Breast Cancers (TNBC) are among the most aggressive and therapy resistant breast tumors. Development of new treatment strategies that target pathways involved in cancer cells resistance is an attractive candidate to overcome therapeutic resistance. Objective: To clarify the antitumor activity of [VO (bpy)2 Cl] Cl complex as new therapeutic agent through studying the interplay between apoptosis, autophagy and notch signaling pathways. Methods: Proliferation of MDA-MB-231 cells and IC50 value of vanadium complex were assessed by MTT assay. Flow cytometry was utilized to detect cell cycle distribution, apoptosis assay, LC3 levels and Acid Vascular Organelles (AVOs). Caspase 3 levels was detected by ELISA. Changes in Notch1 gene expression was assessed by real time PCR. AVOs qualitative detection was assessed by fluorescence microscope. Results: The growth of MDA-MB-231 cells was suppressed after treatment with [VO (bpy)2 Cl] Cl complex, in a dose-dependent manner. The affinity for apoptotic cell death induction was shown through the increase in the sub G0 peak, the percentage of early and late apoptotic phases, and the elevation in caspase 3 levels. The affinity for autophagic cell death induction was observed through the increase in the G0/G1 phase, G2/M arrest, the increase of AVOs red fluorescence and elevated LC3 levels. The affinity for notch pathway inhibition was shown through the suppression of Notch 1 gene expression. Conclusion: [VO (bpy)2 Cl] Cl complex, could be a promising candidate as therapeutic agent targeting different therapeutic targets including apoptosis, autophagy and notch signaling pathways.
- 24 January 2020
- Published by Bentham Science Publishers Ltd. in Anti-Cancer Agents in Medicinal Chemistry
- Vol. 19 (17) , 2130-2139
Possible Selective Cytotoxicity of Vanadium Complex on Breast Cancer Cells Involving Pathophysiological Pathways
Background: Triple-Negative Breast Cancers (TNBC) are among the most aggressive and therapy resistant breast tumors. Development of new treatment strategies that target pathways involved in cancer cells resistance is an attractive candidate to overcome therapeutic resistance. Objective: To clarify the antitumor activity of [VO (bpy)2 Cl] Cl complex as new therapeutic agent through studying the interplay between apoptosis, autophagy and notch signaling pathways. Methods: Proliferation of MDA-MB-231 cells and IC50 value of vanadium complex were assessed by MTT assay. Flow cytometry was utilized to detect cell cycle distribution, apoptosis assay, LC3 levels and Acid Vascular Organelles (AVOs). Caspase 3 levels was detected by ELISA. Changes in Notch1 gene expression was assessed by real time PCR. AVOs qualitative detection was assessed by fluorescence microscope. Results: The growth of MDA-MB-231 cells was suppressed after treatment with [VO (bpy)2 Cl] Cl complex, in a dose-dependent manner. The affinity for apoptotic cell death induction was shown through the increase in the sub G0 peak, the percentage of early and late apoptotic phases, and the elevation in caspase 3 levels. The affinity for autophagic cell death induction was observed through the increase in the G0/G1 phase, G2/M arrest, the increase of AVOs red fluorescence and elevated LC3 levels. The affinity for notch pathway inhibition was shown through the suppression of Notch 1 gene expression. Conclusion: [VO (bpy)2 Cl] Cl complex, could be a promising candidate as therapeutic agent targeting different therapeutic targets including apoptosis, autophagy and notch signaling pathways.
- 1 March 2019
- Published by Elsevier in Advances in Medical Sciences
- Vol. 64 (1) , 202-209
Influence of copper (I) nicotinate complex and autophagy modulation on doxorubicin-induced cytotoxicity in HCC1806 breast cancer cells
- 1 March 2019
- Published by Elsevier in Advances in Medical Sciences
- Vol. 64 (1) , 202-209
Influence of copper (I) nicotinate complex and autophagy modulation on doxorubicin-induced cytotoxicity in HCC1806 breast cancer cells
- 24 November 2017
- Published by Bentham Science Publishers Ltd. in Anti-Cancer Agents in Medicinal Chemistry
- Vol. 17 (11) , 1526-1536
Antitumor Activity of Copper (I)–Nicotinate Complex and Autophagy Modulation in HCC1806 Breast Cancer Cells
Background: Squamous cell cancer is a heterogeneous aggressive disease, therefore, its treatment is challenging. Increased attention has been paid to metal complexes as anticancer drugs. However, new insights towards autophagy have been recognized due to its role in tumor cell death or survival. Objective: To clarify the antitumor activity of copper (I) nicotinate complex (CNC) as new therapeutic agent and understand the role of autophagy modulation as a prospective target for the advancement of efficient therapeutic agent for treatment. Method: Viability of MDA-MB-231 and HCC1806 cells and IC50 values of CNC for both cell lines were assessed by MTT assay. Also, the viability and IC50 values of Torin1 and Chloroquine (CQ) were assessed only in HCC1806 cells by MTT assay. The level of microtubule-associated protein 1 light chain 3 (LC3) was assessed by ELISA. Real time PCR was used to detect the changes in NBR1 gene expression. Cell cycle distribution and quantitative detection of acid vesicular organelles (AVOs) were determined by flow cytometry. Fluorescence microscope was used for qualitative detection of AVOs. Modulation of autophagy was carried out by Torin1 as inducer and CQ as inhibitor. Results: CNC restrained the growth, in a dose-dependent manner, and induced cell death in human HCC1806 cell line. In addition, the CNC treated cells displayed inhibition of autophagy, as indicated by reduction of AVOs, decrease in LC3 protein level and up regulation of NBR1 gene expression. Conclusion: CNC, as an autophagy inhibitor and pro-apoptotic agent, could be a promising anti-cancer agent either alone or in combination with other therapeutic drugs.
- 24 November 2017
- Published by Bentham Science Publishers Ltd. in Anti-Cancer Agents in Medicinal Chemistry
- Vol. 17 (11) , 1526-1536
Antitumor Activity of Copper (I)–Nicotinate Complex and Autophagy Modulation in HCC1806 Breast Cancer Cells
Background: Squamous cell cancer is a heterogeneous aggressive disease, therefore, its treatment is challenging. Increased attention has been paid to metal complexes as anticancer drugs. However, new insights towards autophagy have been recognized due to its role in tumor cell death or survival. Objective: To clarify the antitumor activity of copper (I) nicotinate complex (CNC) as new therapeutic agent and understand the role of autophagy modulation as a prospective target for the advancement of efficient therapeutic agent for treatment. Method: Viability of MDA-MB-231 and HCC1806 cells and IC50 values of CNC for both cell lines were assessed by MTT assay. Also, the viability and IC50 values of Torin1 and Chloroquine (CQ) were assessed only in HCC1806 cells by MTT assay. The level of microtubule-associated protein 1 light chain 3 (LC3) was assessed by ELISA. Real time PCR was used to detect the changes in NBR1 gene expression. Cell cycle distribution and quantitative detection of acid vesicular organelles (AVOs) were determined by flow cytometry. Fluorescence microscope was used for qualitative detection of AVOs. Modulation of autophagy was carried out by Torin1 as inducer and CQ as inhibitor. Results: CNC restrained the growth, in a dose-dependent manner, and induced cell death in human HCC1806 cell line. In addition, the CNC treated cells displayed inhibition of autophagy, as indicated by reduction of AVOs, decrease in LC3 protein level and up regulation of NBR1 gene expression. Conclusion: CNC, as an autophagy inhibitor and pro-apoptotic agent, could be a promising anti-cancer agent either alone or in combination with other therapeutic drugs.